Palvella Therapeutics (PVLA) Operating Income (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -180.13% |
| Dec 31, 2025 | 282.16% |
| Sep 30, 2025 | -10.02% |
| Jun 30, 2025 | -17.52% |
| Mar 31, 2025 | -80.28% |
| Dec 31, 2024 | 13.75% |
| Sep 30, 2024 | -74.07% |
| Jun 30, 2024 | -65.32% |
| Mar 31, 2024 | -113.14% |
| Dec 31, 2023 | 213.37% |
| Sep 30, 2023 | -672.32% |
| Jun 30, 2023 | 113.30% |
| Sep 30, 2022 | 1.31% |
| Jun 30, 2022 | -65.35% |
| Mar 31, 2022 | 32.20% |
| Dec 31, 2021 | 42.15% |
| Sep 30, 2021 | -13.43% |
| Jun 30, 2021 | -231.31% |
| Mar 31, 2021 | 59.24% |
| Dec 31, 2020 | 4.52% |
| Sep 30, 2020 | -179.25% |
| Jun 30, 2020 | -20.72% |
| Mar 31, 2020 | -189.92% |
| Dec 31, 2019 | 54.36% |
| Sep 30, 2019 | 76.17% |
| Jun 30, 2019 | -14.48% |
| Mar 31, 2019 | 15.54% |
| Dec 31, 2018 | -62.07% |
| Sep 30, 2018 | -247.93% |
| Jun 30, 2018 | 72.43% |
| Mar 31, 2018 | -225.40% |
| Dec 31, 2017 | 225.15% |
| Sep 30, 2017 | 34.30% |
| Jun 30, 2017 | 1.44% |
| Mar 31, 2017 | -25.00% |
| Dec 31, 2016 | -3.67% |
| Sep 30, 2016 | -6.60% |
| Jun 30, 2016 | -32.30% |
| Mar 31, 2016 | -70.76% |
| Dec 31, 2015 | 33.88% |
| Sep 30, 2015 | -9.77% |
| Jun 30, 2015 | 4.51% |
| Sep 30, 2014 | 33.53% |
| Jun 30, 2014 | -312.67% |
| Mar 31, 2014 | -30,437.63% |
| Dec 31, 2013 | 61.85% |
| Sep 30, 2013 | -2,002.92% |